Aequus Pharmaceuticals Pauses Sales Of Evolve Intensive Eyedrops, Gel in Canada
Aequus Pharmaceuticals Pauses Sales Of Evolve Intensive Eyedrops, Gel in Canada
Aequs Pharmicals 暂停在加拿大销售 Evolve 密集型眼药水、凝胶
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册